Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Inventiva ADR Representing Ord Shs T.IVA


Primary Symbol: IVA

Healthcare Biotechnology
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.


NDAQ:IVA - Post by User

Inventiva ADR Representing Ord Shs > Interesting, Exciting Company With Great Prope
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by morleymarkleon Nov 14, 2010 8:45pm
301 Views
Post# 17705051

RE: Interesting, Exciting Company With Great Prope

RE: Interesting, Exciting Company With Great Prope
I'm assuming now that IVA is trading on the Toronto exchange, they will be required to provide insider (SEDI) information?

I currently cannot find anything for them on the SEDI website (just IVN and IE).  I would have thought opening balances would at least be required before they would begin trading.  Do they have some kind of 30/60/90/whatever day grace period before providing this information? 

Thx...

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities